Atopic Dermatitis With Coexisting Food Allergy in Early Life Is Associated With Childhood Asthma

Sungsu Jung1, So-Yeon Lee2, Jisun Yoon3

  • 1Department of Pediatrics, Pusan National University Yangsan Hospital, Yangsan, Korea.

Insights

Early-onset persistent atopic dermatitis (AD) with food allergy (FA) in children significantly increases the risk of developing asthma and allergic rhinitis (AR) later in life.

Area of Science:

  • Pediatric Allergy and Immunology
  • Dermatology
  • Respiratory Medicine

Background:

  • Atopic dermatitis (AD) and food allergy (FA) are linked to respiratory conditions, forming the 'atopic march.'
  • The precise mechanisms and disease trajectories, especially concerning coexisting AD and FA, remain incompletely understood.
  • Understanding early-life disease phenotypes is crucial for predicting later respiratory comorbidities.

Purpose of the Study:

  • To investigate if specific phenotypes of AD with coexisting FA in early childhood influence the development of asthma or allergic rhinitis (AR) in school-aged children.
  • To analyze the impact of AD onset and persistence, alongside FA history, on the prevalence of respiratory comorbidities.

Main Methods:

  • A cohort of 1,579 children from the Panel Study on Korean Children (PSKC) was followed.
  • Participants with AD were categorized based on age of onset, persistence, and history of FA.
  • The presence of asthma and AR was compared across different AD phenotypes.

Main Results:

  • Early-onset persistent AD, irrespective of FA, was linked to asthma and AR at ages 6-8.
  • Children with AD and FA exhibited a significantly higher risk of wheezing at age 8 compared to those with AD alone (aOR=8.09).
  • Early-onset persistent AD with FA demonstrated a distinct disease course with increased prevalence of wheezing and AR from ages 5-8.

Conclusions:

  • Early-life AD, particularly when coexisting with FA, strongly predicts asthma and AR in school children.
  • The combination of early-onset persistent AD and FA has an additive effect on asthma risk.
  • Phenotypic classification of early AD, considering FA, is vital for predicting and preventing childhood asthma and AR.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
533
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Allergic Reactions02:06

Allergic Reactions

Overview
28.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
407
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K